Trial · NCT00391872
Results by group32
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 32
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke | TICAGRELOR | 864 | Participants | ||
| Participants With Any Event From the Composite of Death From Vascular Causes, Myocardial Infarction (MI), and Stroke | CLOPIDOGREL | 1014 | Participants | ||
| Participants With Any Major Bleeding Event | TICAGRELOR | 961 | Participants | ||
| Participants With Any Major Bleeding Event | CLOPIDOGREL | 929 | Participants | ||
| Participants With Any Event From the Composite of Death From Vascular Causes, MI, and Stroke for the Subgroup of Patients With Intent for Invasive Management at Randomization | TICAGRELOR | 569 | Participants | ||
| Participants With Any Event From the Composite of Death From Vascular Causes, MI, and Stroke for the Subgroup of Patients With Intent for Invasive Management at Randomization | CLOPIDOGREL | 668 | Participants | ||
| Participants With Any Event From the Composite of All-cause Mortality, MI, and Stroke | TICAGRELOR | 901 | Participants | ||
| Participants With Any Event From the Composite of All-cause Mortality, MI, and Stroke | CLOPIDOGREL | 1065 | Participants | ||
| Participants With Any Event From the Composite of Death From Vascular Causes, MI (Including Silent), Stroke, Recurrent Ischemia, Transient Ischemic Attack (TIA) and Other Arterial Thrombotic Events. | TICAGRELOR | 1290 | Participants | ||
| Participants With Any Event From the Composite of Death From Vascular Causes, MI (Including Silent), Stroke, Recurrent Ischemia, Transient Ischemic Attack (TIA) and Other Arterial Thrombotic Events. | CLOPIDOGREL | 1456 | Participants | ||
| Participants With MI Event | TICAGRELOR | 504 | Participants | ||
| Participants With MI Event | CLOPIDOGREL | 593 | Participants | ||
| Participants With Death From Vascular Causes | TICAGRELOR | 353 | Participants | ||
| Participants With Death From Vascular Causes | CLOPIDOGREL | 442 | Participants | ||
| Participants With Stroke | TICAGRELOR | 125 | Participants | ||
| Participants With Stroke | CLOPIDOGREL | 106 | Participants | ||
| Participants With Death From Any Cause | TICAGRELOR | 399 | Participants | ||
| Participants With Death From Any Cause | CLOPIDOGREL | 506 | Participants | ||
| Participants With Non-CABG (Coronary Artery Bypass Graft) Related Major Bleeding | TICAGRELOR | 362 | Participants | ||
| Participants With Non-CABG (Coronary Artery Bypass Graft) Related Major Bleeding | CLOPIDOGREL | 306 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00391872/results